Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydrogen Peroxide
Therapeutic Area : Dental and Oral Health
Study Phase : Phase III
Sponsor : BMG Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hydrogen Peroxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Periodontitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 25, 2020
Lead Product(s) : Hydrogen Peroxide
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase III
Sponsor : BMG Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hydrogen Peroxide
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : BMG Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hydrogen Peroxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Wound Healing.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 18, 2020
Lead Product(s) : Hydrogen Peroxide
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : BMG Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Polaprezinc
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Azienda Farmaceutica Italiana
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Zinc L-Carnosine Mouth Rinse
Details : Zinc L-Carnosine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
June 16, 2020
Lead Product(s) : Polaprezinc
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Azienda Farmaceutica Italiana
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Study Phase : Phase IV
Sponsor : Regen Lab
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis
Details : Hyaluronic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Osteoarthritis, Knee.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 07, 2017
Lead Product(s) : Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase IV
Sponsor : Regen Lab
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tobramycin
Therapeutic Area : Genetic Disease
Study Phase : Phase IV
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis
Details : Tobramycin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cystic Fibrosis.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
May 31, 2012
Lead Product(s) : Tobramycin
Therapeutic Area : Genetic Disease
Highest Development Status : Phase IV
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable